Navigation Links
MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
Date:9/16/2008

Study 009 meets its primary endpoint of non-inferiority to a rapid-acting

insulin analog

VALENCIA, Calif., Sept. 16 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) today released preliminary top-line results from a Phase 3 clinical study of the Technosphere(R) Insulin System in patients with type 1 diabetes (Study 009). This study compared the safety and efficacy of prandial inhalations of Technosphere Insulin (the TI group) versus prandial subcutaneous injections of insulin aspart (the comparator group). Both groups also received daily subcutaneous injections of a basal insulin (insulin glargine).

Study Highlights

Technosphere Insulin, compared to a rapid-acting insulin analog, showed:

* Comparable reductions in A1C levels

* Comparable numbers of patients reaching pre-defined A1C goals

* Superior fasting blood glucose levels

* Better early post-prandial glucose control

* Fewer patients experiencing hypoglycemic events

* Weight loss versus weight gain

* No adverse effects on pulmonary function

Dr. Peter Richardson, MannKind's Chief Scientific Officer, commented, "We are very pleased with the results of this study, the first of our three completed pivotal Phase 3 studies. These observations confirm the results of earlier studies and build on the important differentiating features of this product, including its positive effects on fasting glucose levels. Technosphere Insulin promises to be an important additional option for the treatment of patients with type 1 diabetes. Our next step is to lock the databases for the remaining two pivotal studies, which further examine long-term efficacy and safety in patients with diabet
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. MannKind Addresses Pfizers Announcement Regarding Exubera
2. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
3. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
4. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
5. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
6. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
7. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
8. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
9. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
10. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
11. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Cohera Medical Inc. today announced the treatment ... its lead surgical adhesive product, TissuGlu®. Initiation of ... company,s progression of the lead product toward clinical ... prospective, open-label, randomized study to investigate the safety ... and associated complications in abdominoplasty, or "tummy tuck," ...
(Date:12/16/2009)... NATICK, Mass., Dec. 16 Boston Scientific Corporation ... Company,s Board of Directors has elected Nelda Connors as ... President of the Electrical and Metal Products division of ... at Eaton Corporation, holding several positions in operations and ... employed in a number of executive and management capacities ...
(Date:12/16/2009)... -- RealMed has been ranked the #1 ... 2009 Top 20 Best in KLAS Awards: ... is a dynamic revenue cycle management solution ... healthcare providers and all payers. ... in vendor performance measurement in the software, ...
Breaking Medicine Technology:First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 1Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 2Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 1Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 2Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 3Palatin Technologies to Present at the Rodman 26 Renshaw 11th Annual Global Investment Conference 13816 1
... at Six-Month Follow-up of 57 Patients, MINNEAPOLIS, ... ), manufacturer and marketer of state-of-the-art cardiac,surgery products, ... and an overall expansion into the stand-alone market,using ... surgical products,indicated for the treatment of cardiac arrhythmias, ...
... Incorporated,(Nasdaq: GPRO ) has submitted to the U.S. ... the additional use of the,PROCLEIX(R) ULTRIO(R) assay to screen ... announced today. The FDA approved the assay to,screen donated ... in late,2006., The Company is seeking approval to ...
Other Medicine Technology:ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line 2ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line 3ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line 4ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line 5Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 2Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 3Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 4
(Date:12/16/2009)... ages, people from around the world have visited Israel,s ... have a reputation that dates back over 2000 years, ... with the introduction of two bath salt lines from ... benefits of Dead Sea salt in their own homes. ... Sea salt and essential oils - but no artificial ...
(Date:12/16/2009)... BOCA RATON, Fla., Dec. 16 Dale Buchanan, owner ... has decided to have a weight loss contest for his ... is that the students are not competing for their own ... to raise money for the Tri County Humane Society ... each student of mine loses between January 4 and February ...
(Date:12/16/2009)... could improve care, but privacy a concern, doctors ... U.S. physicians support the use of electronic medical ... two new studies show. , One study of ... in Massachusetts found that 86 percent believed electronic ... of care, 70 percent thought it would reduce ...
(Date:12/16/2009)... area dry cleaner Dryclean USA donates time and money to help ... ... Dec. 16, 2009 -- South Florida dry cleaner Dryclean USA ... the charity Prints of Hope to help clothe children ... families. Dryclean USA Florida will begin distributing cards, with delivery ...
(Date:12/16/2009)... 16 /PRNewswire-FirstCall/ - TSO3 Inc. ("TSO3") (TSX: TOS) ... has been reached for 3M to be the ... Sterilizer. The partnership with TSO3, an innovator in ... healthcare settings through the use of ozone, will ... through 3M,s global sales channel. This agreement, combined ...
Breaking Medicine News(10 mins):Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:Pros and Cons of Electronic Medical Records Weighed 2Health News:Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4
... American Association of Clinical Endocrinologists (AACE) Fifteenth Annual Meeting ... Regency Chicago between April 26-30 will discuss important benefits ... D deficiency. ,Vitamin D has ... cancer to heart disease has been attributed to it. ...
... According to a large study by Boston University, Black women ... greater risk of breast cancer.// ,The study was published ... Medicine., ,This study is unique because there are previous ... and so it would benefit. ,Lead researcher Dr. Lynn ...
... Over 100 people in Ratlam in Madhya Pradesh fell ill ... in five days in the district, police said Thursday. // ... district hospital, the rest were discharged after first aid, a ... ill after eating at a marriage feast. ,While ...
... diet and ALS saying that a ketogenic- high caloric ... (ALS). // The Mount Sinai School of Medicine is ... neuronal cell death, the cause of ALS. ,According ... which spinal and cortical motor neurons die causing relentlessly ...
... funded the sex-swap surgery of a former sailor is now ... Bainbridge, 57, from Middleton, says she needs the ?2,500 laser ... wear sleevless dresses in the summer. ,Middleton and ... is waiting for a date for surgery at Charing Cross ...
... A new systematic review of studies has found that herbals ... is highly beneficial for treating shot-term low back pain. // ... medication and is found to be better than placebo. ... adults who had acute, sub-acute or chronic low back pain. ...
Other Medicine News:Health News:Herbal Preparation Effective For Treating Short Term Low-Back Pain 2
Polyester ribbon impregnated with conjugated Protein G - .25 OD per sq. cm....
Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Onyx Liquid Embolic System is a device utilized for the pre-surgical embolization of arteriovenous malformations (AVMs)....
... is an accurate, reliable, portable, and ... It works off of a dual-rechargeable ... the device a breeze. The large, ... operating and viewing results simple. Built ...
Medicine Products: